cytarabine has been researched along with Granulomatosis, Lipid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Cai, HC; Cao, XX; Chen, M; Li, J; Liu, T; Zhang, W; Zhou, DB | 1 |
| Cao, XX; Dai, JW | 1 |
| Cao, XX; Li, J; Niu, N; Qiu, Y; Wang, JN; Zhang, Y; Zhou, DB | 1 |
| Liu, SZ; Liu, Y; Song, A; Wang, YP; Zhou, X | 1 |
| Cao, XX; Li, J; Niu, N; Sun, J; Zhou, DB | 1 |
5 other study(ies) available for cytarabine and Granulomatosis, Lipid
| Article | Year |
|---|---|
Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis.
Topics: Cytarabine; Erdheim-Chester Disease; Histiocytosis, Langerhans-Cell; Histiocytosis, Sinus; Humans; Neutropenia | 2022 |
[Sirolimus successfully treated Erdheim-Chester disease with interferon and cytarabine treatment failure: a case report].
Topics: Cytarabine; Erdheim-Chester Disease; Humans; Interferon-alpha; Sirolimus; Treatment Failure | 2023 |
Successful treatment of central nervous system involved Erdheim-Chester disease by intermediate-dose cytarabine as first-line therapy.
Topics: Adult; Central Nervous System Diseases; Cytarabine; Erdheim-Chester Disease; Female; Humans; Immunosuppressive Agents; Prognosis; Young Adult | 2020 |
Exophthalmos and coated aorta in Erdheim-Chester disease.
Topics: Antineoplastic Agents; Cytarabine; Diagnosis, Differential; Diuretics; Erdheim-Chester Disease; Exophthalmos; Humans; Interferon alpha-2; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2020 |
Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease.
Topics: Cytarabine; Drug Therapy, Combination; Erdheim-Chester Disease; Frontal Lobe; Gyrus Cinguli; Histiocytes; Humans; Interferon-alpha; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins B-raf; Recurrence | 2018 |